Figure 6.

Association of B7‐H5/7 and B7‐H6 expression with clinical parameters. (A) In oesophageal cancer, patients with Barrett’s oesophagus, reflux history, history of oesophageal cancer, primary lymph node presentation, columnar metaplasia, tumour neoplasm and tumour lymph node metastasis have significantly higher level of B7‐H5/H7 mRNA expression. Moreover, B7‐H5/H7 expression level was negatively correlated with tumour differentiation grade. (B) In liver cancer, patients with higher neoplasm stage and poor disease‐free survival have higher level of B7‐H6. *P < .05, **P < .01 and ***P < .001